Garrett Gray - Feb 27, 2023 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
Chief Financial Officer
Signature
/s/ Garrett Gray
Stock symbol
CKPT
Transactions as of
Feb 27, 2023
Transactions value $
-$26,874
Form type
4
Date filed
3/3/2023, 07:00 PM
Previous filing
Feb 3, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT Common Stock Sale -$8.92K -1.91K -3.88% $4.66 47.5K Feb 27, 2023 Direct F1, F2, F3
transaction CKPT Common Stock Award $0 +7.5K +15.8% $0.00 55K Feb 27, 2023 Direct F3, F4
transaction CKPT Common Stock Sale -$18K -3.59K -6.53% $5.00 51.4K Mar 2, 2023 Direct F3, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the vesting of 3,925 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F2 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.65 to $4.69. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes shares of restricted common stock, which vest over various time periods.
F4 Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on February 27, 2023.
F5 In connection with the vesting of 7,500 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F6 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $5.00 to $5.025. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.